BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12375034)

  • 21. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
    Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gastrointestinal stromal tumors. Observations on the basis of 29 cases].
    Sápi Z; Kovács RB; Bodó M
    Orv Hetil; 2001 Nov; 142(45):2479-85. PubMed ID: 11778355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
    Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
    Kleer CG; Giordano TJ; Braun T; Oberman HA
    Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
    Sabah M; Cummins R; Leader M; Kay E
    Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.
    Pollack A; Cowen D; Troncoso P; Zagars GK; von Eschenbach AC; Meistrich ML; McDonnell T
    Cancer; 2003 Apr; 97(7):1630-8. PubMed ID: 12655519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract].
    Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H
    Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy.
    Kamijo T; Yokose T; Hasebe T; Yonou H; Sasaki S; Hayashi R; Ebihara S; Miyahara H; Hosoi H; Ochiai A
    Clin Cancer Res; 2000 Aug; 6(8):3159-65. PubMed ID: 10955798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors.
    Motegi A; Sakurai S; Nakayama H; Sano T; Oyama T; Nakajima T
    Pathol Int; 2005 Mar; 55(3):106-12. PubMed ID: 15743318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistopathological and molecular genetic features of a case in which gastrointestinal stromal tumor recurred five times.
    Inoue T; Suzuki T; Nakagawa K; Kurokawa Y; Satomi S; Moriya T; Sasano N; Sasano H
    Pathol Int; 2004 Mar; 54(3):196-200. PubMed ID: 14989743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
    Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor].
    Ma D; Liu X; Cai Z; Xie Q
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma.
    Kaseta MK; Khaldi L; Gomatos IP; Tzagarakis GP; Alevizos L; Leandros E; Papagelopoulos PJ; Soucacos PN
    J Surg Oncol; 2008 Mar; 97(3):259-66. PubMed ID: 18161867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gastrointestinal stromal tumors: a broad clinical spectrum from incidental -discovery to acute gastrointestinal bleeding].
    Siewert E; Tietze L; Maintz C; Geier A; Dietrich CG; Matern S; Gartung C
    Z Gastroenterol; 2004 Mar; 42(3):233-42. PubMed ID: 15022111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.